Fig. 3From: Predictive value of delta radiomics in xerostomia after chemoradiotherapy in patients with stage III-IV nasopharyngeal carcinoma15, 10, and 12 optimal subsets selected in pretreatment (A), after IC (B), and Delta (C) radiomics features, respectivelyBack to article page